Related Articles
First-line single-agent chemotherapy for patients with recurrent or metastatic gastric cancer with poor performance status
Declines in serum CYFRA21-1 and carcinoembryonic antigen as predictors of chemotherapy response and survival in patients with advanced non-small cell lung cancer
Prognostic and predictive value of CEA and CYFRA 21-1 levels in advanced non-small cell lung cancer patients treated with gefitinib or erlotinib
Glasgow Prognostic Score is superior to ECOG PS as a prognostic factor in patients with gastric cancer with peritoneal seeding
Prognostic value of circulating tumor cells in advanced gastric cancer patients receiving chemotherapy